返回 Agenda
Session Chair(s)
Xue TANG
Drug Safety Unit Regional Head (DRH),
APAC Pfizer, China
Speaker(s)
Introduction on "Guidance on the On-Site Inspection of Adverse Drug Reaction Reporting and Monitoring by Manufacturing Enterprises"
Duo Dong
China Food and Drug Administration (CFDA), China
Deputy Division Director, National Center for ADA Monitoring
Pharmacovigilance Inspections - Perspectives on Preparation and Management
Helen Li, MD, MBA
Pfizer Medical, China
Director, Emerging Market QA Asia Lead
Yuan Yao
Novartis China, China
Head of PVO China, AD